Seaport Therapeutics SPTX
$18.05 −$0.27 (-1.47%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.05 0.00%
Open$18.02
Prev close$18.32
Day range$17.41 – $18.83
Volume284.3K
Market cap$966.23M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$30.35M-19.3% YoY
Net profit-$26.39M-17.1% YoY
Diluted EPS-$0.49-15.3% YoY
Free cash flow-$22.68M-43.8% YoY
Operating cash flow-$22.68M
Revenue, last 7 quarters
Net profit, last 7 quarters
Diluted EPS by quarter
Free cash flow by quarter
Profitability & balance sheet
Return on equity-34.9%
Return on assets-33.2%
Return on invested capital-36.2%
Current ratio17.48
Liabilities / assets4.8%
Cash & investments$290.43M
Total debt$3.06M
Net cash (debt)$287.37M
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL |
|---|---|---|---|---|---|
| Operating Cash Flow | -$22.68M | -$26.14M | -$20.17M | -$26.65M | -$77.94M |
| Effect of Exchange Rate Changes | -$5,000.00 | $29,000.00 | -$28,000.00 | -$28,000.00 | $3,000.00 |
| Beginning Cash Balance | $64.68M | $53.36M | $46.50M | $46.39M | $309.55M |
| Net Change in Cash | -$2.67M | $11.29M | $6.90M | $136,000.00 | -$263.06M |
| Ending Cash Balance | $62.01M | $64.68M | $53.36M | $46.50M | $46.50M |
| Proceeds from Stock Option Exercised | $0.00 | – | – | $0.00 | $1,000.00 |
| Net Common Stock Issuance | -$97,000.00 | – | – | – | – |
| Net Cash Flow from Continuing Financing Activities | -$97,000.00 | $240.93M | -$783,000.00 | -$874,000.00 | -$873,000.00 |
| Financing Cash Flow | -$97,000.00 | $240.93M | -$783,000.00 | -$874,000.00 | -$873,000.00 |
| Free Cash Flow | -$22.68M | -$26.14M | -$20.17M | -$26.67M | -$78.30M |
| Net Investment Purchase and Sale | $20.11M | -$203.50M | $27.85M | $27.68M | -$183.89M |
| Net PPE Purchase and Sale | $0.00 | $0.00 | $0.00 | -$25,000.00 | -$356,000.00 |
| -Change in Prepaid Assets | $247,000.00 | -$2.00M | $1.57M | -$1.73M | -$6.21M |
| Net Income from Continuing Operations | -$26.39M | -$62.60M | -$25.41M | -$24.14M | -$74.88M |
| Depreciation & Depletion & Amortization | $358,000.00 | $351,000.00 | $357,000.00 | $364,000.00 | $1.41M |
| Change in Working Capital | $1.45M | -$396,000.00 | $2.53M | -$4.14M | -$7.93M |
| Net cash flow from continuing operations | -$22.68M | -$26.14M | -$20.17M | -$26.65M | -$77.94M |
| -Change in Payables and Accrued Expense | $1.54M | $1.94M | $1.29M | -$1.76M | $877,000.00 |
| -Change in Other Current Assets | $0.00 | $0.00 | $0.00 | -$365,000.00 | -$1.56M |
| -Change in Other Current Liabilities | -$330,000.00 | -$329,000.00 | -$323,000.00 | -$285,000.00 | -$1.04M |
| Net Cash Flow from Continuing Investing Activities | $20.11M | -$203.50M | $27.85M | $27.66M | -$184.25M |
| Net cash flow from investing | $20.11M | -$203.50M | $27.85M | $27.66M | -$184.25M |
| Net Other Financing Charges | – | – | -$783,000.00 | – | -$874,000.00 |
| Gain/Loss from Continuing Operations | – | – | – | – | $11,000.00 |
| Net Preferred Stock Issuance | – | – | – | – | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Other Non-Current Assets | $454,000.00 | $454,000.00 | $3.84M | $2.88M | $2.88M |
| Total Liabilities | $20.17M | $19.08M | $343.29M | $341.55M | $341.55M |
| Total Current Liabilities | $17.11M | $15.67M | $14.22M | $12.78M | $12.78M |
| Payables | $7.27M | $5.71M | $4.80M | $2.01M | $2.01M |
| -Accounts Payable | $5.81M | $5.71M | $4.79M | $2.01M | $2.01M |
| -Total Tax Payable | $1.45M | – | – | – | – |
| -Due to Related Parties Current | $0.00 | $0.00 | $11,000.00 | $7,000.00 | $7,000.00 |
| Current Accrued Expenses | $3.97M | $5.29M | $6.11M | $3.94M | $3.94M |
| Short-Term Debt and Capital Lease Obligation | $1.62M | $1.61M | $1.60M | $1.64M | $1.64M |
| -Current Capital Lease Obligation | $1.62M | $1.61M | $1.60M | $1.64M | $1.64M |
| Total Non-Current Liabilities | $3.06M | $3.41M | $329.07M | $328.77M | $328.77M |
| Investments and Advances | $113.37M | $153.95M | $30.04M | $17.67M | $17.67M |
| -Accumulated Depreciation | -$1.07M | -$1.04M | -$1.02M | -$989,000.00 | -$989,000.00 |
| -Gross PPE | $5.81M | $6.14M | $6.47M | $6.21M | $6.21M |
| Total Assets | $417.62M | $441.68M | $227.67M | $249.01M | $249.01M |
| Total Current Assets | $299.06M | $282.18M | $188.34M | $223.23M | $223.23M |
| Cash and Cash Equivalents & Short-Term Investments | $290.43M | $273.31M | $182.61M | $215.98M | $215.98M |
| -Cash and Cash Equivalents | $61.55M | $64.22M | $52.91M | $46.04M | $46.04M |
| -Short Term Investments | $228.88M | $209.09M | $129.70M | $169.94M | $169.94M |
| Receivables | $4.72M | $4.86M | $3.28M | $3.03M | $3.03M |
| -Accrued Interest Receivable | $2.40M | $2.72M | $1.38M | $1.73M | $1.73M |
| -Taxes Receivable | $2.33M | $2.14M | $1.89M | $1.30M | $1.30M |
| Prepaid Assets | $3.91M | $4.01M | $2.46M | $4.22M | $4.22M |
| Total Non-Current Assets | $118.56M | $159.51M | $39.33M | $25.78M | $25.78M |
| Net PPE | $4.74M | $5.10M | $5.45M | $5.23M | $5.23M |
| Long Term Debt and Capital Lease Obligation | $3.06M | $3.41M | $3.74M | $3.44M | $3.44M |
| -Long Term Capital Lease Obligation | $3.06M | $3.41M | $3.74M | $3.44M | $3.44M |
| Convertible preferred securities | $0.00 | $0.00 | $325.33M | $325.33M | $325.33M |
| Total Equity | $397.46M | $422.60M | -$115.62M | -$92.55M | -$92.55M |
| Stockholders' Equity | $397.46M | $422.60M | -$115.62M | -$92.55M | -$92.55M |
| Capital Stock | $5,000.00 | $5,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -Common Stock | $5,000.00 | $5,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -Preferred Stock | $0.00 | – | – | – | – |
| Additional Paid-In Capital | $627.64M | $625.19M | $23.83M | $21.26M | $21.26M |
| Retained Earnings | -$228.51M | -$202.12M | -$139.52M | -$114.11M | -$114.11M |
| Gains/Losses Not Affecting Retained Earnings | -$1.68M | -$475,000.00 | $64,000.00 | $301,000.00 | $301,000.00 |
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Profit from Continuing Operations | -$26.39M | -$62.60M | -$25.41M | -$74.88M | -$24.14M |
| Net Profit | -$26.39M | -$62.60M | -$25.41M | -$74.88M | -$24.14M |
| Tax | $127,000.00 | $251,000.00 | $519,000.00 | $773,000.00 | $513,000.00 |
| Pretax Profit | -$26.27M | -$62.35M | -$24.89M | -$74.11M | -$23.62M |
| Other Non-Operating Income (Expenses) | $178,000.00 | $202,000.00 | $521,000.00 | $1.78M | $1.06M |
| Other Income (Expense) | $178,000.00 | $202,000.00 | $521,000.00 | $1.78M | $1.06M |
| Non-Operating Interest Income | $3.90M | $3.26M | $2.13M | $11.40M | $2.52M |
| Research & Development | $23.89M | $24.62M | $21.43M | $66.31M | $21.92M |
| -General & Admin Expense | $6.45M | $41.19M | $6.11M | $20.98M | $5.28M |
| Selling and Admin Expenses | $6.45M | $41.19M | $6.11M | $20.98M | $5.28M |
| Operating Expense | $30.35M | $65.81M | $27.54M | $87.29M | $27.20M |
| Net Income to Parent Company | -$26.39M | -$62.60M | -$25.41M | -$74.88M | -$24.14M |
| Net Income to Common Stockholders | -$26.39M | -$62.60M | -$25.41M | -$74.88M | -$24.14M |
| Basic EPS | -$0.49 | -$1.78 | -$0.48 | -$1.94 | -$0.46 |
| Diluted EPS | -$0.49 | -$1.78 | -$0.48 | -$1.94 | -$0.46 |
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Profit | -$30.35M | -$65.81M | -$27.54M | -$87.29M | -$27.20M |
| Net Non-Operating Interest Income (Expense) | $3.90M | $3.26M | $2.13M | $11.40M | $2.52M |
No comments yet — be the first to weigh in on SPTX.
Sign in to join the discussion.